The United States is of paramount importance for Swiss medical technology. Twenty-five percent of all exports go to the U.S., which is by far the largest single market for our industry. At the same time, the U.S. is an important supplier for the Swiss healthcare system. On the list of the most important countries of origin for imports, the U.S. ranks first with Germany.
From a Swiss perspective, the fact that we have a positive trade balance with practically every country is very pleasing. This is also the case with the U.S., where our trade surplus has steadily increased over the last few years and now stands at CHF 1.5 billion per year.
In this report, we provide a comprehensive guide to navigating the U.S. medical technology market. Our roadmap outlines key steps for a successful market entry. We also shed light on market barriers and challenges, offering insights to help you overcome hurdles and make informed decisions in this dynamic industry.
